Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence
Open Access
- 1 January 2008
- journal article
- clinical trial
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 14 (14), 2187-2193
- https://doi.org/10.3748/wjg.14.2187
Abstract
AIM: To investigate biological prevention with flavonoids the recurrence risk of neoplasia was studied in patients with resected colorectal cancer and after adenoma polypectomy. METHODS: Eighty-seven patients, 36 patients with resected colon cancer and 51 patients after polypectomy, were divided into 2 groups: one group was treated with a flavonoid mixture (daily standard dose 20 mg apigenin and 20 mg epigallocathechin-gallat, n = 31) and compared with a matched control group (n = 56). Both groups were observed for 3-4 years by surveillance colonoscopy and by questionnaire. RESULTS: Of 87 patients enrolled in this study, 36 had resected colon cancer and 29 of these patients had surveillance colonoscopy. Among the flavonoid-treated patients with resected colon cancer (n = 14), there was no cancer recurrence and one adenoma developed. In contrast the cancer recurrence rate of the 15 matched untreated controls was 20% (3 of 15) and adenomas evolved in 4 of those patients (27%). The combined recurrence rate for neoplasia was 7% (1 of 14) in the treated patients and 47% (7 of 15) in the controls (P = 0.027). CONCLUSION: Sustained long-term treatment with a flavonoid mixture could reduce the recurrence rate of colon neoplasia in patients with resected colon cancer.Keywords
This publication has 38 references indexed in Scilit:
- Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studiesThe Lancet, 2007
- Calcium and Vitamin D Intake and Risk of Colorectal Cancer: The Multiethnic Cohort StudyAmerican Journal of Epidemiology, 2007
- Celecoxib for the Prevention of Sporadic Colorectal AdenomasThe New England Journal of Medicine, 2006
- Flavonoid Intake and Colorectal Cancer Risk in Men and WomenAmerican Journal of Epidemiology, 2006
- Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysisThe Lancet, 2004
- Green tea and gastrointestinal cancer riskAlimentary Pharmacology & Therapeutics, 2004
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasThe New England Journal of Medicine, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal CancerThe New England Journal of Medicine, 2003
- Inhibition of Carcinogenesis by TeaAnnual Review of Pharmacology and Toxicology, 2002
- Dietary flavonoids and cancer risk in the Zutphen elderly studyNutrition and Cancer, 1994